266 related articles for article (PubMed ID: 24261582)
1. The effect of blood coagulation factor XIII on fibrin clot structure and fibrinolysis.
Hethershaw EL; Cilia La Corte AL; Duval C; Ali M; Grant PJ; Ariëns RA; Philippou H
J Thromb Haemost; 2014 Feb; 12(2):197-205. PubMed ID: 24261582
[TBL] [Abstract][Full Text] [Related]
2. Compaction of fibrin clots reveals the antifibrinolytic effect of factor XIII.
Rijken DC; Abdul S; Malfliet JJ; Leebeek FW; Uitte de Willige S
J Thromb Haemost; 2016 Jul; 14(7):1453-61. PubMed ID: 27148673
[TBL] [Abstract][Full Text] [Related]
3. Factor XIII cotreatment with hemostatic agents in hemophilia A increases fibrin α-chain crosslinking.
Beckman JD; Holle LA; Wolberg AS
J Thromb Haemost; 2018 Jan; 16(1):131-141. PubMed ID: 29080382
[TBL] [Abstract][Full Text] [Related]
4. FXIII polymorphisms, fibrin clot structure and thrombotic risk.
Kobbervig C; Williams E
Biophys Chem; 2004 Dec; 112(2-3):223-8. PubMed ID: 15572253
[TBL] [Abstract][Full Text] [Related]
5. Plasma fibrin clots of pulmonary embolism patients present increased amounts of factor XIII and alpha2-antiplasmin at 3 months' anticoagulation since the acute phase.
Zabczyk M; Natorska J; Bagoly Z; Sarkady F; Barath B; Katona E; Bryk A; Zettl K; Wisniewski JR; Undas A
J Physiol Pharmacol; 2020 Aug; 71(4):. PubMed ID: 33214340
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of Fibrinolysis by Coagulation Factor XIII.
Rijken DC; Uitte de Willige S
Biomed Res Int; 2017; 2017():1209676. PubMed ID: 28761875
[TBL] [Abstract][Full Text] [Related]
7. Role of factor XIII in ischemic stroke: a key molecule promoting thrombus stabilization and resistance to lysis.
Marta-Enguita J; Navarro-Oviedo M; Machado FJDM; Bermejo R; Aymerich N; Herrera M; Zandio B; Pagola J; Juega J; Marta-Moreno J; Rodriguez JA; Páramo JA; Roncal C; Muñoz R; Orbe J
J Thromb Haemost; 2024 Apr; 22(4):1080-1093. PubMed ID: 38160727
[TBL] [Abstract][Full Text] [Related]
8. Significance of cross-linking of alpha 2-plasmin inhibitor to fibrin in inhibition of fibrinolysis and in hemostasis.
Sakata Y; Aoki N
J Clin Invest; 1982 Mar; 69(3):536-42. PubMed ID: 7199538
[TBL] [Abstract][Full Text] [Related]
9. Zinc promotes clot stability by accelerating clot formation and modifying fibrin structure.
Henderson SJ; Xia J; Wu H; Stafford AR; Leslie BA; Fredenburgh JC; Weitz DA; Weitz JI
Thromb Haemost; 2016 Mar; 115(3):533-42. PubMed ID: 26489782
[TBL] [Abstract][Full Text] [Related]
10. Model thrombi formed under flow reveal the role of factor XIII-mediated cross-linking in resistance to fibrinolysis.
Mutch NJ; Koikkalainen JS; Fraser SR; Duthie KM; Griffin M; Mitchell J; Watson HG; Booth NA
J Thromb Haemost; 2010 Sep; 8(9):2017-24. PubMed ID: 20586921
[TBL] [Abstract][Full Text] [Related]
11. Incorporation of α2-Plasmin Inhibitor into Fibrin Clots and Its Association with the Clinical Outcome of Acute Ischemic Stroke Patients.
Bagoly Z; Baráth B; Orbán-Kálmándi R; Szegedi I; Bogáti R; Sarkady F; Csiba L; Katona É
Biomolecules; 2021 Feb; 11(3):. PubMed ID: 33669007
[TBL] [Abstract][Full Text] [Related]
12. Factor XIII stiffens fibrin clots by causing fiber compaction.
Kurniawan NA; Grimbergen J; Koopman J; Koenderink GH
J Thromb Haemost; 2014 Oct; 12(10):1687-96. PubMed ID: 25142383
[TBL] [Abstract][Full Text] [Related]
13. Factor XIIIa-dependent retention of red blood cells in clots is mediated by fibrin α-chain crosslinking.
Byrnes JR; Duval C; Wang Y; Hansen CE; Ahn B; Mooberry MJ; Clark MA; Johnsen JM; Lord ST; Lam WA; Meijers JC; Ni H; Ariëns RA; Wolberg AS
Blood; 2015 Oct; 126(16):1940-8. PubMed ID: 26324704
[TBL] [Abstract][Full Text] [Related]
14. Factor XIII and Fibrin Clot Properties in Acute Venous Thromboembolism.
Ząbczyk M; Natorska J; Undas A
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562624
[TBL] [Abstract][Full Text] [Related]
15. Factor XIII (FXIII) and angiogenesis.
Dardik R; Loscalzo J; Inbal A
J Thromb Haemost; 2006 Jan; 4(1):19-25. PubMed ID: 16129024
[TBL] [Abstract][Full Text] [Related]
16. Evidence that alpha2-antiplasmin becomes covalently ligated to plasma fibrinogen in the circulation: a new role for plasma factor XIII in fibrinolysis regulation.
Mosesson MW; Siebenlist KR; Hernandez I; Lee KN; Christiansen VJ; McKee PA
J Thromb Haemost; 2008 Sep; 6(9):1565-70. PubMed ID: 18564219
[TBL] [Abstract][Full Text] [Related]
17. Clot retraction increases clot resistance to fibrinolysis by condensing alpha 2-plasmin inhibitor crosslinked to fibrin.
Aoki N
Thromb Haemost; 1993 Aug; 70(2):376. PubMed ID: 8236154
[No Abstract] [Full Text] [Related]
18. Promotion of the crosslinking of fibrin and alpha 2-antiplasmin by platelets.
Hevessy Z; Haramura G; Boda Z; Udvardy M; Muszbek L
Thromb Haemost; 1996 Jan; 75(1):161-7. PubMed ID: 8713796
[TBL] [Abstract][Full Text] [Related]
19. Protransglutaminase (factor XIII) mediated crosslinking of fibrinogen and fibrin.
Siebenlist KR; Meh DA; Mosesson MW
Thromb Haemost; 2001 Nov; 86(5):1221-8. PubMed ID: 11816711
[TBL] [Abstract][Full Text] [Related]
20. Factor XIII and venous thromboembolism.
Bereczky Z; Muszbek L
Semin Thromb Hemost; 2011 Apr; 37(3):305-14. PubMed ID: 21455864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
